J. Sagar Associates advised Axis Capital Limited and ICICI Securities Limited (together the “BRLMs”) in relation to the proposed initial public offering of Rossari Biotech Limited (Rossari). Rossari has filed a draft red herring prospectus with the Securities and Exchange Board of India for an offer of equity shares comprising a fresh issue of up to ₹ 1,500 million and an offer for sale of up to 10.50 million equity shares by the promoters of Rossari, namely, Edward Walter Menezes and Sunil Srinivasan Chari.

Rossari is one of the leading specialty chemicals manufacturing companies in India, providing customized solutions to specific industrial and production requirements of our customers primarily in the FMCG, apparel, poultry and animal feed industries through their diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products. They operate in India as well as in 17 foreign countries including Vietnam, Bangladesh and Mauritius. They are the largest manufacturer of textile specialty chemicals in India providing textile specialty chemicals in a sustainable, eco-friendly yet competitive manner. JSA Team comprised Partners Vikram Raghani and Arka Mookerjee; Principal Associate Siddhartha Desai; Associates Krupa Brahmbhatt, Ananth Balaji, Kairav Parikh and Kinjal Shah.